Login / Signup
Siyun Lin
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 3
Top Topics
Squamous Cell
Neoadjuvant Chemotherapy
Study Protocol
Phase Iii
Top Venues
Nature medicine
Clinical and experimental pharmacology & physiology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Lijie Tan
,
Jingnan Yuan
,
Yunjin Li
,
Yong Fang
,
Ruoxi Wang
,
Heng Jiao
,
Han Tang
,
Shaoyuan Zhang
,
Siyun Lin
,
Feng Su
,
Jianmin Gu
,
Tian Jiang
,
Dong Lin
,
Zhiliang Huang
,
Chaoxiang Du
,
Kui Wu
,
Lijie Tan
,
Qing Zhou
Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial.
Nature medicine
(2023)
Shaoyuan Zhang
,
Linyi Sun
,
Borong Chen
,
Siyun Lin
,
Jianmin Gu
,
Lijie Tan
,
Miao Lin
Telocytes protect against lung tissue fibrosis through hexokinase 2-dependent pathway by secreting hepatocyte growth factor.
Clinical and experimental pharmacology & physiology
(2023)
Lijie Tan
,
Jingnan Yuan
,
Yunjin Li
,
Yong Fang
,
Ruoxi Wang
,
Heng Jiao
,
Han Tang
,
Shaoyuan Zhang
,
Siyun Lin
,
Feng Su
,
Jianmin Gu
,
Tian Jiang
,
Dong Lin
,
Zhiliang Huang
,
Chaoxiang Du
,
Kui Wu
,
Lijie Tan
,
Qing Zhou
Publisher Correction: Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial.
Nature medicine
(2023)